Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
WbW8P09HU3huaLwr
